Study aim: Determination of axillary lymph node status is crucial in diagno
sis of early breast cancer. However thanks to an early diagnosis, an increa
sing number of axillary lymph node dissections are free of disease. This ra
ises questions about the need for this procedure. The study aim was to repo
rt an experience with lymphadenectomy and sentinel node mapping in patients
with T0-T1 carcinoma of the breast.
Methods: Between November 1997 and December 1999, 84 consecutive women (T0-
T1 NO according to the 1987 UICC classification) with recently diagnosed br
east cancer, were included in this study for identification of the sentinel
lymph node (SLN). The SLN was removed and submitted for histological exami
nation. All patients underwent axillary dissection; nodes from levels I and
II (Berg's classification) were excised and submitted to histological exam
ination.
Results: The average tumor diameter was 12,7 mm (range, 3 to 25 mm). The ly
mphatic mapping technique was obtained after injection of the isotope into
the breast around the tumor in 53/84 patients: the sentinel lymph node was
the only positive node in 10 patients and it was positive in 5 patients wit
h other axillary nodes. In 15/84 patients, an intradermal injection of blue
dye was used; two sentinel nodes were positive and one falsely negative. I
n 16/84 patients, an interdermal injection of blue dye was used to make up
for. In this study, the sentinel node was positive in three patients and fa
lsely negative in one patient. The discrepancy was due to an important invo
lvement of an axillary area excluded from the lymphatic channels. 22/84 pat
ients (26%) had a metastatic spread to the axillary nodes. 30/84 patients h
ad also an isotopic captation in another lymph node group (internal mammary
).
Conclusion: This study confirms that lymphatic mapping is technically possi
ble in the patients with T0-T1 breast cancer and that the histological char
acteristics of the sentinel node probably reflect the histological characte
ristics of the rest of the axillary lymph nodes, but do not provide any inf
ormation about the other lymph node sites. (C) 2001 Editions scientifiques
et medicales Elsevier SAS.